Cat: IPD-X34174

Recombinant Human FGFR-1 beta (IIIc) Protein (HEK293),Avi & His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • Gene name

    FGFR-1 beta (IIIc)

  • 简介

    FGFR-1 alpha is a tyrosine-protein kinase receptor for fibroblast growth factor that is critical in embryonic development, cell proliferation, differentiation, and migration. GnRH is essential for mesodermal patterning, axial organization, skeletogenesis, and nervous system development. FGFR-1 beta (IIIc) Protein, Human (HEK293, His-Avi) is the recombinant human-derived FGFR-1 beta, expressed by HEK293 , with C-Avi, C-His labeled tag.

  • Application

    SPRMSTBLIITCELISACELL ASSAYDRUG SCREENING

  • Biological Activity

    1.Immobilized Anti-FGFR1 Anitibody, hFc Tag at 2 μg/mL (100 μl/Well)on the plate. Dose response curve for Human FGFR1 beta (Illc), His Tag with the EC50 of ≤ 0.34 μg/mL determined by ELISA. 2.Immobilized Human FGFR1 beta (IIIc) at 0.5 μg/mL (100 μL/Well) on the plate. Dose response curve for Anti-FGFR1 Antibody with the ED50 of 0.3177 μg/mL determined by ELISA. Immobilized Human FGFR1 beta (IIIc) at 0.5 μg/mL (100 μL/Well) on the plate. Dose response curve for Anti-FGFR1 Antibody with the ED50 of 0.3177 μg/mL determined by ELISA.

  • Alternative Names

    Fibroblast growth factor receptor 1; FGFR-1; BFGFR; bFGF-R-1; FLT-2; CD331;

  • Species

    Human

  • Source

    HEK293

  • Tag

    C-Avi;C-His

  • Purity

    Greater than 95% as determined by SDS-PAGE.

  • Uniprot

    P11362-7

  • Expression Region

    K158-T355

  • AA Sequence

    KMEKKLHAVPAAKTVKFKCPSSGTPNPTLRWLKNGKEFKPDHRIGGYKVRYATWSIIMDSVVPSDKGNYTCIVENEYGSINHTYQLDVVERSPHRPILQAGLPANKTVALGSNVEFMCKVYSDPQPHIQWLKHIEVNGSKIGPDNLPYVQILKTAGVNTTDKEMEVLHLRNVSFEDAGEYTCLAGNSIGLSHHSAWLT

  • Protein Length

    Partial

  • Molecular Weight

    40-55 kDa.

  • Endotoxin

    < 1.0 EU per μg protein as determined by the LAL method.

  • Form

    Freeze-dried powder

  • Buffer formulation

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • Reconstitution

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • Customization

    Site-directed mutagenesis Custom tag design Custom buffer formulation Custom full-length protein production

  • Stability Test

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • Storage & Shelf Life

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • Shipping

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

Fibroblast Growth Factor Receptor 1 (FGFR-1) plays a crucial role in various biological processes, including cell proliferation, differentiation, and angiogenesis. The receptor exists in several isoforms, with FGFR-1 beta (IIIc) being particularly significant in the context of cancer biology. This isoform has been linked to tumorigenesis, as it is often over-expressed in various malignancies and is associated with tumor growth and metastasis. Research has shown that FGFR-1 beta (IIIc) mediates signaling pathways that promote cancer cell survival and invasiveness, making it a potential therapeutic target. The development of recombinant FGFR-1 beta (IIIc) proteins allows for detailed investigations into its structure, function, and interactions with ligands. Such studies are essential for the validation of FGFR-1 beta (IIIc) as a biomarker for cancer diagnostics and as a target for novel treatment strategies. Understanding the molecular mechanisms underlying its role in cancer may provide insights into new therapies that can inhibit its function, thereby offering hope for improved outcomes in cancer treatment.

E-mail

sales@ipodix.com

Sales

+1 2092920560


Contact us via WhatsApp

IPODIX Biotech Inc

2108 N ST, STE N
Sacramento, CA 95816, USA

For Product Information and Orders

sales@ipodix.com

For Business Collaboration

sales@ipodix.com

For CRO Services

sales@ipodix.com

For Technical Support

sales@ipodix.com
  • 50000+

    Recombinant Proteins

  • 100+

    Researchers

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US